Magnetoelastic (ME) materials have many advantages for use as sensors and actuators due to their wireless, passive nature. This paper describes the application of ME materials as biodegradable implants with controllable degradation rates. Experiments have been conducted to show that degradation rates of ME materials are dependent on the material compositions. In addition, it was shown that the degradation rates of the ME materials can be controlled remotely by applying a magnetic field, which causes the ME materials to generate low-magnitude vibrations that hasten their degradation rates. Another concern of ME materials for medical applications is biocompatibility. Indirect cytotoxicity analyses were performed on two types of ME materials: Metglas™ 2826 MB (FeNiMoB) and iron–gallium alloy. While results indicate Metglas is not biocompatible, the degradation products of iron–gallium materials have shown no adverse effects on cell viability. Overall, these results present the possibility of using ME materials as biodegradable, magnetically-controlled active implants.
Evidence is presented showing that commonly isolated Bacillus spp. liberate volatiles which inhibit growth and cause lysis of cyanobacteria. Anabaena spp. were particularly sensitive. A simple, convenient method is described which allows the culture of permutations of physically segregated Bacillus and cyanobacteria, whilst sharing a common atmosphere. The extent of antagonism of cyanobacteria was directly related to the amount of Bacillus growth and appears to be temporally linked with sporulation in the bacilli. Low incubation temperatures (approx. 20°C) decreased the antagonistic effect, as did the presence of activated charcoal or soil at normal temperature (30°C). Gram-negative bacteria and some green algae were also affected.
Revision total knee replacement is a challenging surgical procedure typically associated with significant loss of bone stock in the proximal tibia. To increase the fixation stability, extended stems are frequently used for the tibial component in revision surgery. The design of the tibial stem influences the load transfer from tibial component to the surrounding bone and is cited as a possible cause for the clinically reported pain in the location of the stem-end. This study aimed to analyse the strain distribution of a fully cemented revision tibial component with a validated finite element model. The model was developed from a scanned composite tibia (Sawbones), with an implanted, fully cemented stemmed tibial component aligned to the mechanical axis of the tibia. Loading was applied to the tibial component with mediolateral compartment load distributions of 60:40 and 80:20. Three strain gauged composite tibias with implanted tibial components of the same design using the same loading distribution were tested to obtain experimental strains at five locations in the proximal tibia. The finite element model developed was validated against strain measurements obtained in the experimental study. The strains displayed similar patterns (R(2) = 0.988) and magnitudes with those predicted from the finite element model. The displacement of the stem-end from the natural mechanical axis in the finite element model demonstrated increased strains in the stem-end region with a close proximity of the distal stem with the cortical bone. The simulation of a mediolateral compartment load of 80:20 developed peak cortical strain values on the posterior-medial side beneath the stem. This may possibly be related to the clinically reported pain at the stem-end. Furthermore, stem positioning in close proximity or contact with the posterior cortical bone is a contributory factor for an increase in distal strain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.